» Articles » PMID: 1463092

Interobserver Reproducibility in the Diagnosis of Ductal Proliferative Breast Lesions Using Standardized Criteria

Overview
Date 1992 Dec 1
PMID 1463092
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Although the categorization of proliferative breast lesions provides valuable information regarding subsequent risk of breast cancer, the ability of pathologists to classify such lesions in a reproducible fashion has not been adequately evaluated. To assess further interobserver reproducibility in the categorization of proliferative breast lesions, six pathologists each reviewed 24 proliferative ductal lesions and classified them as either usual hyperplasia (H), atypical hyperplasia (AH), or carcinoma in situ (CIS). Before evaluation of the study slides, all the participants were instructed to use the diagnostic criteria of Page and co-workers and were provided with both a written summary of these criteria and a set of teaching slides with representative examples of each type of lesion. Complete agreement among all six pathologists was seen in 14 cases (58%); five or more agreed in 17 cases (71%); and four or more arrived at the same diagnosis in 22 cases (92%). No pathologist consistently rendered more "benign" or "malignant" diagnoses than any other. After assigning numerical values for each diagnostic category (H = 1, AH = 2, CIS = 3), the scores for the group of 24 cases did not differ significantly by pathologist (p = 0.68; average score range, 1.7-2.0). Our results indicate that with the use of standardized criteria, interobserver concordance in the diagnosis of proliferative ductal breast lesions can be obtained in the majority of cases.

Citing Articles

Preneoplastic Low-Risk Mammary Ductal Lesions (Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ Spectrum): Current Status and Future Directions.

Khoury T Cancers (Basel). 2022; 14(3).

PMID: 35158775 PMC: 8833401. DOI: 10.3390/cancers14030507.


Atypical ductal hyperplasia of the breast mimics breast cancer presentation treated surgically: a case report and literature review.

Alwagdani N, Alnefaie S, Kurshid A, Kewan H J Surg Case Rep. 2021; 2021(7):rjab325.

PMID: 34336186 PMC: 8318601. DOI: 10.1093/jscr/rjab325.


SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3.

Pang J, Castles B, Byrne D, Button P, Hendry S, Lakhani S Am J Surg Pathol. 2021; 45(8):1108-1117.

PMID: 34232604 PMC: 8277187. DOI: 10.1097/PAS.0000000000001701.


Deep learning-based grading of ductal carcinoma in situ in breast histopathology images.

Wetstein S, Stathonikos N, Pluim J, Heng Y, Ter Hoeve N, Vreuls C Lab Invest. 2021; 101(4):525-533.

PMID: 33608619 PMC: 7985025. DOI: 10.1038/s41374-021-00540-6.


Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.

Dano H, Altinay S, Arnould L, Bletard N, Colpaert C, Dedeurwaerdere F Mod Pathol. 2019; 33(3):354-366.

PMID: 31534203 PMC: 7983551. DOI: 10.1038/s41379-019-0367-9.